During the past decade, LKH Hohenems; Abteilung für Pulmologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "LKH Hohenems; Abteilung für Pulmologie" are "Idiopathic Pulmonary Fibrosis" (1 trials) and "Non-Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "LKH Hohenems; Abteilung für Pulmologie" in a lesser frequency.

Most popular intervention types in "LKH Hohenems; Abteilung für Pulmologie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Docetaxel" (1 trials), "Erlotinib" (1 trials), "Pemetrexed" (1 trials) and "Pirfenidone" (1 trials). Other intervention names were less common.

The vast majority of trials in "LKH Hohenems; Abteilung für Pulmologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "LKH Hohenems; Abteilung für Pulmologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in LKH Hohenems; Abteilung für Pulmologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in LKH Hohenems; Abteilung für Pulmologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".